Metropolitan Life Insurance Company (MetLife)’s N-able NABL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,964
Closed -$51.8K 1347
2024
Q1
$51.8K Hold
3,964
﹤0.01% 1387
2023
Q4
$52.5K Hold
3,964
﹤0.01% 1424
2023
Q3
$51.1K Buy
3,964
+287
+8% +$3.91K ﹤0.01% 1384
2023
Q2
$53K Hold
3,677
﹤0.01% 1385
2023
Q1
$48.5K Sell
3,677
-648
-15% -$7.16K ﹤0.01% 1408
2022
Q4
$44.5K Hold
4,325
﹤0.01% 1550
2022
Q3
$39.9K Hold
4,325
﹤0.01% 1604
2022
Q2
$38.9K Buy
+4,325
New +$42.4K ﹤0.01% 1657
2022
Q1
Sell
-788
Closed -$8.75K 2526
2021
Q4
$8.75K Buy
788
+2
+0.3% +$25 ﹤0.01% 2775
2021
Q3
$9.75K Buy
+786
New +$10.8K ﹤0.01% 2835

Other funds holding NABL

Metropolitan Life Insurance Company (MetLife)'s NABL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of N-able (NABL) in Q2 2024, closing a stake of 3,964 shares — an estimated $51.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NABL in Q3 2021 and held it in 10 quarters. The position peaked at $53K in Q2 2023. 193 funds tracked by Wall St. Rank hold NABL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining N-able position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,964 N-able shares in Q2 2024, an estimated $51.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in N-able in Q3 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s N-able position peaked at $53K in Q2 2023.
  • 193 funds tracked by Wall St. Rank held N-able as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.